Lauren A V Orenstein
Overview
Explore the profile of Lauren A V Orenstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
310
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pulminskas A, Hojjatie R, Karatas T, Li Y, Orenstein L
Dermatol Clin
. 2025 Mar;
43(2):247-260.
PMID: 40023625
Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition that may cause debilitating pain and itch. Given their physical and psychological burden, recognition and treatment of HS-associated symptoms are critical...
2.
Li Y, Speck P, Ingram J, Orenstein L
Arch Dermatol Res
. 2025 Feb;
317(1):496.
PMID: 40009252
Pain is the most impactful and burdensome symptom of hidradenitis suppurativa (HS) and profoundly affects patients' quality of life. There is variation in how trials measure HS pain, with some...
3.
Trupiano N, Young K, Echuri H, Maghfour J, Orenstein L, Hamzavi I
J Dermatol
. 2025 Jan;
52(2):239-246.
PMID: 39812242
Itch is a prominent symptom in many cutaneous disorders, including atopic dermatitis (AD), prurigo nodularis, and psoriasis. Itch is also a common but overlooked concern in patients with hidradenitis suppurativa...
4.
Orenstein L, Barbieri J, Siira M, Borre E, Supapannachart K, Viera E, et al.
JAMA Dermatol
. 2024 Dec;
PMID: 39714835
Importance: Clinical productivity measures may incentivize clinical care to specific patient populations and thus perpetuate inequitable care. Before the 2021 Medicare physician fee schedule changes, outpatient dermatology encounters for patients...
5.
Surapaneni V, Milosavljevic M, Orenstein L
J Am Acad Dermatol
. 2024 Dec;
91(6S):S52-S63.
PMID: 39627001
Pain is the most impactful symptom in hidradenitis suppurativa (HS), contributing to physical limitations, worsened mental health, and impaired social relationships. Some HS-directed therapies ameliorate HS pain; however, these medications...
6.
Jain S, Tushe S, Sood A, Yeung H, Orenstein L
Arch Dermatol Res
. 2024 Jul;
316(7):445.
PMID: 38955839
Hidradenitis suppurativa (HS) is a chronic inflammatory cutaneous disease that often leads to decreased quality of life. Prior research assessing stress and discrimination related to stigmatization of those with HS...
7.
Salame N, Sow Y, Siira M, Garg A, Chen S, Patzer R, et al.
JAMA Dermatol
. 2024 Jan;
160(2):179-186.
PMID: 38198173
Importance: Despite the US Food and Drug Administration's approval of adalimumab for the treatment of hidradenitis suppurativa (HS), prescription rates remain low, indicating a critical gap between evidence-based guidelines and...
8.
Mastacouris N, Tannenbaum R, Strunk A, Koptyev J, Aarts P, Alhusayen R, et al.
JAMA Dermatol
. 2023 Sep;
159(11):1258-1266.
PMID: 37755725
Importance: Although several clinician- and patient-reported outcome measures have been developed for trials in hidradenitis suppurativa (HS), there is currently no consensus on which measures are best suited for use...
9.
Li Y, Speck P, Viera E, Siira M, Orenstein L
Dermatology
. 2023 Sep;
239(6):1007-1012.
PMID: 37717562
Background: Pain and itch are impactful and burdensome symptoms of hidradenitis suppurativa (HS). Elucidating factors associated with pain and itch severity may identify groups disproportionally affected by HS-related pain and...
10.
Alsouhibani A, Speck P, Cole E, Mustin D, Li Y, Barron J, et al.
JAMA Dermatol
. 2023 Sep;
159(10):1102-1111.
PMID: 37702999
Importance: Pain is the most impactful symptom in patients with hidradenitis suppurativa (HS). Characterization of sensory profiles may improve understanding of pain mechanisms in HS and facilitate identification of effective...